Passage Bio, Inc.

PASG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Aug 1, 2024 FORM 8-K
8-K Jul 16, 2024 8-K
SC 13D/A May 29, 2024 SC 13D/A
4 May 23, 2024
4 May 23, 2024
4 May 23, 2024
4 May 23, 2024
4 May 23, 2024
4 May 23, 2024
8-K May 22, 2024 FORM 8-K
424B3 May 14, 2024 424B3
10-Q May 14, 2024 10-Q
8-K May 14, 2024 8-K
EFFECT Apr 16, 2024
CORRESP Apr 12, 2024
SC 13D/A Apr 12, 2024 AMENDMENT NO. 4
DEFA14A Apr 9, 2024 DEFA14A
DEF 14A Apr 9, 2024 DEF 14A
ARS Apr 9, 2024 ARS
SC 13G Mar 29, 2024 PASSAGE BIO, INC.
4 Mar 19, 2024
4 Mar 19, 2024
4 Mar 19, 2024
4 Mar 19, 2024
UPLOAD Mar 7, 2024
← Newer Page 6 of 18 · 442 filings Older →